Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 170

Similar articles for PubMed (Select 23122981)

1.

Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.

Yang H, Hu W, Wang W, Chen P, Ding W, Luo W.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e47-54. doi: 10.1016/j.ijrobp.2012.09.033. Epub 2012 Nov 1.

PMID:
23122981
2.

Sustained improvement of quality of life for nasopharyngeal carcinoma treated by intensity modulated radiation therapy in long-term survivors.

Song T, Fang M, Zhang XB, Zhang P, Xie RF, Wu SX.

Int J Clin Exp Med. 2015 Apr 15;8(4):5658-66. eCollection 2015.

3.
4.

Incidence of and Risk Factors for Mastoiditis after Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma.

Yao JJ, Zhou GQ, Yu XL, Tang LL, Chen L, Mao YP, Lin L, Zhang LL, Shao JY, Guo Y, Ma J, Sun Y.

PLoS One. 2015 Jun 26;10(6):e0131284. doi: 10.1371/journal.pone.0131284. eCollection 2015.

5.

Quality of life of nasopharyngeal cancer survivors in China.

Hong JS, Tian J, Han QF, Ni QY.

Curr Oncol. 2015 Jun;22(3):e142-7. doi: 10.3747/co.22.2323.

6.

Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy.

Li AC, Xiao WW, Shen GZ, Wang L, Xu AA, Cao YQ, Huang SM, Lin CG, Han F, Deng XW, Zhao C.

Oncotarget. 2015 May 28. [Epub ahead of print]

7.

Olfactory change after intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Wang JJ, Liang KL, Twu CW, Lin JC, Jiang RS.

Int Forum Allergy Rhinol. 2015 Jun 16. doi: 10.1002/alr.21575. [Epub ahead of print]

PMID:
26077632
8.

Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated by intensity modulated radiotherapy (IMRT) VERSUS non-IMRT.

Huang TL, Chien CY, Tsai WL, Liao KC, Chou SY, Lin HC, Luo SD, Lee TF, Lee CH, Fang FM.

Head Neck. 2015 Jun 3. doi: 10.1002/hed.24150. [Epub ahead of print]

PMID:
26041548
9.

Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma - A case-matched comparison.

You R, Zou X, Hua YJ, Han F, Li L, Zhao C, Hong MH, Chen MY.

Radiother Oncol. 2015 May 16. pii: S0167-8140(15)00221-2. doi: 10.1016/j.radonc.2015.04.024. [Epub ahead of print]

PMID:
25987536
10.

Late sensorial alterations in different radiotherapy techniques for nasopharyngeal cancer.

Riva G, Raimondo L, Ravera M, Moretto F, Boita M, Potenza I, Rampino M, Ricardi U, Garzaro M.

Chem Senses. 2015 May;40(4):285-92. doi: 10.1093/chemse/bjv011. Epub 2015 Mar 23.

PMID:
25800268
11.

Actual anatomical and dosimetric changes of parotid glands in nasopharyngeal carcinoma patients during intensity modulated radiation therapy.

Ren G, Xu SP, Du L, Feng LC, Qu BL, Liu HX, Xie CB, Ma L.

Biomed Res Int. 2015;2015:670327. doi: 10.1155/2015/670327. Epub 2015 Feb 22.

12.

Advances and challenges in intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Qu S, Liang ZG, Zhu XD.

Asian Pac J Cancer Prev. 2015;16(5):1687-92.

13.

Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.

Cao CN, Luo JW, Gao L, Yi JL, Huang XD, Wang K, Zhang SP, Qu Y, Li SY, Xiao JP, Zhang Z, Xu GZ.

PLoS One. 2015 Mar 6;10(3):e0119101. doi: 10.1371/journal.pone.0119101. eCollection 2015.

14.

Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer : Results of a prospective study.

Tribius S, Raguse M, Voigt C, Münscher A, Gröbe A, Petersen C, Krüll A, Bergelt C, Singer S.

Strahlenther Onkol. 2015 Jun;191(6):501-510. Epub 2015 Mar 8.

PMID:
25747264
15.

Post-irradiation otitis media, rhinosinusitis, and their interrelationship in nasopharyngeal carcinoma patients treated by IMRT.

Hsin CH, Tseng HC, Lin HP, Chen TH.

Eur Arch Otorhinolaryngol. 2015 Jan 30. [Epub ahead of print]

PMID:
25634060
17.

Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma.

Tsai WL, Huang TL, Liao KC, Chuang HC, Lin YT, Lee TF, Huang HY, Fang FM.

BMC Cancer. 2014 Nov 21;14:856. doi: 10.1186/1471-2407-14-856.

18.

Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of China.

Wang R, Tan Y, Wang X, Ma L, Wang D, Hu Y, Qin Y, Liu K, Chang C, Yu J.

PLoS One. 2014 Nov 6;9(11):e111145. doi: 10.1371/journal.pone.0111145. eCollection 2014.

19.

Factors predict prolonged wait time and longer duration of radiotherapy in patients with nasopharyngeal carcinoma: a multilevel analysis.

Chen PC, Yang CC, Wu CJ, Liu WS, Huang WL, Lee CC.

PLoS One. 2014 Oct 14;9(10):e109930. doi: 10.1371/journal.pone.0109930. eCollection 2014.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk